---
title: Effect of Heart Failure Pharmacotherapies in Patients with Heart Failure with
  Mildly Reduced Ejection Fraction
date: '2024-03-21'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38513366/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240322180509&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSION: BB, ACEi/ARB/ARNI and SGLT2i were independently associated
  with lower risk of all-cause mortality in patients with HFmrEF, specifically when
  applied as combined "HF triple therapy". Randomized studies are needed to investigate
  the effect of HF-related pharmacotherapies in patients with ...'
disable_comments: true
---
CONCLUSION: BB, ACEi/ARB/ARNI and SGLT2i were independently associated with lower risk of all-cause mortality in patients with HFmrEF, specifically when applied as combined "HF triple therapy". Randomized studies are needed to investigate the effect of HF-related pharmacotherapies in patients with ...